ACLARION INC

Insider buying at ACLARION spikes—CEO, CFO, and owner buy shares at $2.73, signaling confidence in its AI‑driven healthcare tech and potential upside.

Insider buying at Aclarion Inc. shows growing confidence in its AI‑driven diagnostics—CFO and execs keep buying, hinting at value upside.

Insider buying by Aclarion Inc.’s board member signals cautious optimism in a bearish market, hinting at hidden value in its AI‑driven health‑tech platform.